chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Pain in extremity, Peripheral swelling
Clinical narrative: Joint pain in the 5th finger (pinky) of the left arm, swelling present along the finger and left wrist. Symptom began the next day after vaccination. Vaccine administered 11/24/21. Symptom present on 11/25 & 11/26, unknown if it will be present for the next few days or resolution of symptoms.
Age: 14.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Dysarthria, Fall, Hyperhidrosis, Immediate post-injection reaction
Clinical narrative: They both had reactions to the flu shot.  both within 30 seconds after their shots.  Patient's muscles tensed up, she fell off her chair, and she was out for a few seconds.  Then, she also started to feel faint.  911 was called.  Both girls were sweaty and needed to remove their masks.  Patient stayed on the floor with her dada holding her while she remained in the seat.  Patient was up and talking within a few seconds, but quickly began to become sleepy and started slurring her words.  Paramedics arrived on the scene and took both girls to the hospital.
Age: 14.0
Sex: F
Vaccine: FLU4
Symptoms: Loss of consciousness, Muscle tightness, Somnolence
Clinical narrative: They both had reactions to the flu shot.  both within 30 seconds after their shots.  Patient's muscles tensed up, she fell off her chair, and she was out for a few seconds.  Then, she also started to feel faint.  911 was called.  Both girls were sweaty and needed to remove their masks.  Patient stayed on the floor with her dada holding her while she remained in the seat.  Patient was up and talking within a few seconds, but quickly began to become sleepy and started slurring her words.  Paramedics arrived on the scene and took both girls to the hospital.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: NO ADVERSE EVENT OCCURRED. PATIENT RECEIVED A BOOSTER DOSE OF THE PFIZER VACCINE AT AN OFF-SITE CLINIC. PATIENT WAS UNDER THE AGE OF 18 AT THE TIME OF ADMINISTRATION.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Pruritus, Rash vesicular
Clinical narrative: About 2 weeks after shot, my back became covered with extremely itchy blister-like eruptions.  The same thing happened to me back in April of 2021 when I received my second Moderna shot.  I was uncertain then that it was connected to the Covid vaccine, but since it has happened again with the booster, and in the same time frame (2-3 weeks after receiving shot) I thought I should report it. It has been 2-3 days now since onset, and the blisters and itchiness seems to be receding.  As I recall, it took about 5 days for this reaction to go away back in April.  Anecdotally, when I mentioned this to my sister, she said her husband had a similar reaction to the Moderna vaccine.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient is 17 years old and was given a booster when boosters are only approved for those 18 years and older. On 11/23/21 when the error was discovered we contacted the patient's father and informed him of the error. The patient was fine at the time of this call. A follow up call was conducted on 11/26/21 and the father reported that his son was still feeling fine and no adverse events to report.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injection site erythema, Injection site swelling
Clinical narrative: Fever, chills, swelling & redness at the injection,  muscle & joint aches, skin pain & sensitivity,  headache
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain of skin, Pyrexia
Clinical narrative: Fever, chills, swelling & redness at the injection,  muscle & joint aches, skin pain & sensitivity,  headache
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: NO ADVERSE EVENT OCCURRED. PATIENT RECEIVED A BOOSTER DOSE OF THE PFIZER VACCINE AT AN OFF-SITE CLINIC. PATIENT WAS UNDER THE AGE OF 18 AT THE TIME OF ADMINISTRATION.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: NO ADVERSE EVENTS OCCURRED. PATIENT RECEIVED A BOOSTER DOSE OF THE PFIZER VACCINE AT AN OFF-SITE CLINIC. PATIENT WAS UNDER THE AGE OF 18 AT THE TIME OF ADMINISTRATION.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Swelling face, Urticaria
Clinical narrative: Patient developed an urticarial reaction the day after he received his first dose of the Pfizer COVID-19 vaccine.  The rash was generalized throughout his entire body.  His face was also swollen.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Emotional distress, Hyperventilation
Clinical narrative: Patient presented very upset, confused initially, as well as hyperventilating. Her vital signs consistently stayed normal. Clear lung sounds and pulse oximeter of 99% on room air.  Patient then transported to hospital.
Age: 12.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Dysarthria, Fall, Hyperhidrosis, Immediate post-injection reaction
Clinical narrative: Two patients both had reactions to the flu shot.  both within 30 seconds to a minute.  First patient muscles tensed up . she fell of the chair, and she passed out for a few seconds.  Then , second patient also started to feel faint.  911 was called.  Both girls were sweaty and needed to remove her mask.  First patient stayed on the floor with her dada holding her.  Second patient remained in the chair.  First patient was up and talking within a few seconds, but quickly began to become sleepy and started slurring her words.  Paramedics arrived on the scene and transported both girls to the hospital.
Age: 12.0
Sex: F
Vaccine: FLU4
Symptoms: Loss of consciousness, Muscle tightness, Somnolence
Clinical narrative: Two patients both had reactions to the flu shot.  both within 30 seconds to a minute.  First patient muscles tensed up . she fell of the chair, and she passed out for a few seconds.  Then , second patient also started to feel faint.  911 was called.  Both girls were sweaty and needed to remove her mask.  First patient stayed on the floor with her dada holding her.  Second patient remained in the chair.  First patient was up and talking within a few seconds, but quickly began to become sleepy and started slurring her words.  Paramedics arrived on the scene and transported both girls to the hospital.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: patient did not have any symptoms just received the higher dose on the booster shot.
Age: 41.0
Sex: F
Vaccine: HEP
Symptoms: Injection site mass, Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: Employee received her second dose of Hep B. on 11/26/2021. Upon completion of the injection donor stated that she had a knot (ball) in deltoid after her first injection. This site is covered with a tattoo from the shoulder joint to the bottom of the deltoid muscle most of the ink was red. Employee stated that there was a big knot(ball) in injection site. Employee stated that she rubbed it, put ice on it, and also heat trying to get the pain to stop and the knot(ball) to go down. She stated that this took almost two weeks to go down and once it did the area was sore and tender to touch (and still is) once this knot (ball) went away it began to itch and get bumps. Today all she stated is that it was tender and sore to touch.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Lip swelling, Rash
Clinical narrative: chronic swollen lip , heavy chest heaving, chronic rash outbreak  persisted following vaccine
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Ear pain, Nerve injury, Tinnitus
Clinical narrative: Started feeling twinges in the internal left ear like 4 times one day, the next day the same, and started to hear like white noise only in the left ear.
Age: 60.0
Sex: U
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Condition aggravated, Death
Clinical narrative: patient admitted for stroke 10/20-11/2/2021. received Pfizer vaccine 10/28/2021. discharged to SAR 11/2/2021. date of death = 11/20/2021.
Age: 75.0
Sex: F
Vaccine: FLU4
Symptoms: Dyspnoea, Feeling abnormal, Pruritus, Pyrexia
Clinical narrative: Patient called the pharmacy and reported that after her vaccine she felt "bad". She had fever and itching and some SOB. It lasted about 24 hours then went away.  She did not report to the md but wanted to make sure that the pharmacy knew. She said a new guy had given her vaccine and she just wanted to make sure he knew what he was doing.  She was reassured that all staff administering  vaccines had been properly trained.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Asthenia, Blood potassium decreased, Chest X-ray, Chronic left ventricular failure
Clinical narrative: Patient presents to ED after Cardiology called him to come in due to low potassium.  Denies muscle aching or chest pains at this time.  Does state he is feeling bloated despite having a hard stool about an hour ago.    1. Hypokalemia    2. Electrolyte depletion    3. Weakness    4. Left arm numbness    5. Chronic systolic CHF (congestive heart failure) potassium chloride (KLOR-CON M20) 20 MEQ CR tablet
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Electrolyte depletion, Full blood count, Hypokalaemia, Injection site hypoaesthesia
Clinical narrative: Patient presents to ED after Cardiology called him to come in due to low potassium.  Denies muscle aching or chest pains at this time.  Does state he is feeling bloated despite having a hard stool about an hour ago.    1. Hypokalemia    2. Electrolyte depletion    3. Weakness    4. Left arm numbness    5. Chronic systolic CHF (congestive heart failure) potassium chloride (KLOR-CON M20) 20 MEQ CR tablet
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test
Clinical narrative: Patient presents to ED after Cardiology called him to come in due to low potassium.  Denies muscle aching or chest pains at this time.  Does state he is feeling bloated despite having a hard stool about an hour ago.    1. Hypokalemia    2. Electrolyte depletion    3. Weakness    4. Left arm numbness    5. Chronic systolic CHF (congestive heart failure) potassium chloride (KLOR-CON M20) 20 MEQ CR tablet
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Breast tenderness, Erythema, Fatigue, Headache
Clinical narrative: I was vaccinated on 11/20.  I experienced a significant headache and fatigue for 3 days after my vaccination.  I noticed a slight dip in my supply beginning on 11/21, but it wasn't significant.  I then began to notice some slight tenderness and what felt like a clogged milk duct in my right breast on Wednesday 11/24.  By Thursday evening (11/25), I began to experience significant pain, increased tenderness, and redness in the same area. I also experienced body aches, a headache and a fever.  By Friday 11/26, I noticed a significant drop in my milk production (from approximately 15 ounces per pump, to approximately 8 ounces per pump).
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding, Pain, Pyrexia, Suppressed lactation
Clinical narrative: I was vaccinated on 11/20.  I experienced a significant headache and fatigue for 3 days after my vaccination.  I noticed a slight dip in my supply beginning on 11/21, but it wasn't significant.  I then began to notice some slight tenderness and what felt like a clogged milk duct in my right breast on Wednesday 11/24.  By Thursday evening (11/25), I began to experience significant pain, increased tenderness, and redness in the same area. I also experienced body aches, a headache and a fever.  By Friday 11/26, I noticed a significant drop in my milk production (from approximately 15 ounces per pump, to approximately 8 ounces per pump).
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac disorder, Cardioversion
Clinical narrative: I have recently since October 2021 have had heart issues with A fib and now it is requiring a second hospital visit per my cardio doctor to resolve the A fib condition with another cardio version with in 45 days along with beta blockers
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Hyperaesthesia teeth, Myalgia, Tremor
Clinical narrative: ache in hamstrings, later in upper back; shaking for a short time after awakening.  Slight temp:  100-101.  Teeth felt sensitive (I ate only an orange, grapes and an apple on Saturday).  This lasted from Friday through Sunday.  Monday I felt wonderful.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: The patient was vaccinated with a booster shot before the six month period.  The patient also received 3 Moderna injections prior to the number giving the booster shot (04/20/21; 04/22/21;05/18/2021; 11/05/2021)
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No symptoms to date. Booster dose was given sooner than 6 months after second dose. Patient did not show any signs of reaction so far, just reporting that booster was given earlier than 6 months after second dose.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling of eyelid
Clinical narrative: Patient came into the pharmacy and was asked about his 2nd covid vaccine, he state that he had a reaction after the first shot.  he said that he suffers from barometric sinus eye when he flies.  he had a reaction similar to that his upper eyelid swelled and was red and itchy this lasted for about 8 hours before it resolved. he was advised to contact his md before he received the second dose. he said he was between mds but would check with his new md. he was called a couple of weeks later but he had still not been evaluated by his new md he was waiting on an appointment
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Diarrhoea, Feeling abnormal, Lymph node pain, Lymphadenopathy
Clinical narrative: temperature up to 101.5, on and off up and down over 3 days, Large swollen lymph nodes under right arm (half a tennis ball size or bigger) and those in the neck were also very tender.  Lymph nodes back to normal by 5 days. Felt pretty lousy.  Diahrreah on the first day about 6 hours after injection but temperature and other symptoms started about 9 the night of the injection.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID + 9/20/21
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Facial pain, Herpes zoster, Sinusitis, Swelling face
Clinical narrative: Developed shingles-herpes zoster exactly 8 days post vaccine administration. While I know that this virus can develop at any time after having the chicken pox virus the timing is curious in relation to the vaccine.  Thought it may be a tooth abscess at first, went to the dentist and was diagnosed with sinusitis and was given antibiotics Amoxi/Clav 825mg.  After being on antibiotic for 36+ hours with no improvement worsening facial swelling and pain. Four days after initial symptoms of facial pain then swelling, blister/sores began to immerge and worsening of facial swelling and pain. The only reason that this was diagnosed was that other persons had developed shingles post vaccine, and friends and family stated that's what it looked like. Upon this went to the ER and was properly diagnosed with Shingles given IM Prednisone and Morphine unsure of dosage and prescribed Accylovir 800 MG 1 tablet PO 5x/7 days; Prednisone 50 MG 1 tablet PO daily/5 days; some PO pain medication.  No previous Shingle outbreak.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: Patient received a Moderna booster at the pharmacy today, it was discovered their 2nd Moderna was on 8/13/2021. The patient was ineligible for their booster dose until 2/19/2022.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Diffuse rash on trunk, bilateral arms and legs
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Extreme fatigue, headache, low grade fever.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Syringe issue
Clinical narrative: The syringe malfunctioned when the needle was in the patient's arm. The plunger wouldn't move toward the needle. I filled another syrine and gave the vaccine to the patient.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives Benedryl  Cleared up within a day of taking benedryl
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Gait disturbance, Joint range of motion decreased, Nausea
Clinical narrative: Low-grade fever began about 12 hours after vaccination. Pain in vaccine site (right arm) became intense. Arm was nearly immobile, pain radiated throughout the whole arm into the hand. Patient went to sleep, woke at 6:00 am, and was unable to go back to sleep because of arm pain. Patient got out of bed at 6:45 am, urinated, and went into the cabinet to retrieve Advil. Patient suddenly became very nauseous and went towards the kitchen to try to vomit in the trash can. Patient's roommate was in the living room and reported the patient was breathing heavily and stumbling towards the kitchen. Patient then collapsed on the kitchen floor. Roommate helped the patient sit up and the patient vomited for 1 minute. Patient began to recover and called her doctor. Patient has no history of fainting or vaccine/needle anxiety.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Sleep disorder, Syncope
Clinical narrative: Low-grade fever began about 12 hours after vaccination. Pain in vaccine site (right arm) became intense. Arm was nearly immobile, pain radiated throughout the whole arm into the hand. Patient went to sleep, woke at 6:00 am, and was unable to go back to sleep because of arm pain. Patient got out of bed at 6:45 am, urinated, and went into the cabinet to retrieve Advil. Patient suddenly became very nauseous and went towards the kitchen to try to vomit in the trash can. Patient's roommate was in the living room and reported the patient was breathing heavily and stumbling towards the kitchen. Patient then collapsed on the kitchen floor. Roommate helped the patient sit up and the patient vomited for 1 minute. Patient began to recover and called her doctor. Patient has no history of fainting or vaccine/needle anxiety.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Low-grade fever began about 12 hours after vaccination. Pain in vaccine site (right arm) became intense. Arm was nearly immobile, pain radiated throughout the whole arm into the hand. Patient went to sleep, woke at 6:00 am, and was unable to go back to sleep because of arm pain. Patient got out of bed at 6:45 am, urinated, and went into the cabinet to retrieve Advil. Patient suddenly became very nauseous and went towards the kitchen to try to vomit in the trash can. Patient's roommate was in the living room and reported the patient was breathing heavily and stumbling towards the kitchen. Patient then collapsed on the kitchen floor. Roommate helped the patient sit up and the patient vomited for 1 minute. Patient began to recover and called her doctor. Patient has no history of fainting or vaccine/needle anxiety.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Presyncope
Clinical narrative: 2nd dose pfizer vaccine:  Vaso vagal response immediately post vaccination, lasted 5 seconds. Given snacks , sent to ED accompanied by mom in stable  condition
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Loss of consciousness
Clinical narrative: Patient felt fine after shot.  They were informed to remain in the store for 15 minutes for observation.  They were walking up the aisle and started to feel faint.  Vision went black and patient passed out.   Mom yelled out and laid the patient down on the ground.   911 was called.  Patient quickly came to, feet were elevated and they were resting.   Pulse was checked.  Patient was talking and felt fine but just sad and scared.  After a few minutes she sat up and leaved against the shelves.   At that point emergency personnel arrived and took over.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Antibody test negative, Aspartate aminotransferase normal, Blood alkaline phosphatase increased, Blood bilirubin normal
Clinical narrative: Pt and family reported small bruises around the vaccine injection site (L deltoid) within 24 hours of receiving the Pt's first COVID-19 Vaccine.  Within the next few days Pt noticed multiple other bruises on both arms, shoulders, hands, and thighs.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Blood urine present, Chromaturia, Coagulation factor VIII level, Contusion
Clinical narrative: Pt and family reported small bruises around the vaccine injection site (L deltoid) within 24 hours of receiving the Pt's first COVID-19 Vaccine.  Within the next few days Pt noticed multiple other bruises on both arms, shoulders, hands, and thighs.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Differential white blood cell count, Full blood count abnormal, Haematocrit decreased, Haemoglobin decreased, Injection site bruising
Clinical narrative: Pt and family reported small bruises around the vaccine injection site (L deltoid) within 24 hours of receiving the Pt's first COVID-19 Vaccine.  Within the next few days Pt noticed multiple other bruises on both arms, shoulders, hands, and thighs.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell volume normal, Mean platelet volume decreased, Occult blood negative, Platelet count normal
Clinical narrative: Pt and family reported small bruises around the vaccine injection site (L deltoid) within 24 hours of receiving the Pt's first COVID-19 Vaccine.  Within the next few days Pt noticed multiple other bruises on both arms, shoulders, hands, and thighs.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Protein urine present, Red blood cell count decreased, Red cell distribution width normal, Streptococcus test negative, Urinary system X-ray
Clinical narrative: Pt and family reported small bruises around the vaccine injection site (L deltoid) within 24 hours of receiving the Pt's first COVID-19 Vaccine.  Within the next few days Pt noticed multiple other bruises on both arms, shoulders, hands, and thighs.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Von Willebrand's factor antigen test, White blood cell count normal
Clinical narrative: Pt and family reported small bruises around the vaccine injection site (L deltoid) within 24 hours of receiving the Pt's first COVID-19 Vaccine.  Within the next few days Pt noticed multiple other bruises on both arms, shoulders, hands, and thighs.
Age: 61.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Patient became light-headed and unresponsive; fainted. The nurse administering the vaccines lowered her from a chair onto the floor and made sure she was still breathing. I called 911 to get an ambulance sent to our location.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Patient received the first dose of pediatric Pfizer on 11/19/2021. He started feeling sick on 11/21/2021, and then diagnosed COVID-19 positive on 11/23/2021.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Oropharyngeal pain, Paraesthesia oral, Somnolence, Vertigo
Clinical narrative: Patient was given booster (3rd) dose of Moderna covid 19 vaccine. approximately 10 minutes after administration she started getting faint, and said "the room is spinning". I put a cold pack on the back of her neck and checked her blood pressure it was approximately 165/110. She never lost consciousness, but reported being very sleepy. She started to report that her throat hurt and her lips were tingling. With patients husbands permission we called 911. The operator asked if she had an epi-pen, her husband reported she did and pulled it out of her bag, he gave her the epi-pen on the advice of the 911 operator, at that point the EMT arrived and took over and transported her to the hospital.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Vomiting
Clinical narrative: Syncope and vomiting at 10 am 11/25 after receiving booster at 7 pmOn 11/24.   Second heat syncope incident at 5 pm same day (11/25), but she had barely eaten all day.   No vomiting second time and once syncope was over, ate normally, sipped Gatorade and lemonade and has been fine since. Taking Extra Strength Tylenol every 4 hrs.  Has been fine all day 11/26 but continuing Tylenol today as a precaution.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Pfizer vaccine was given to patient under 18
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: patient was booked onto a 12+ vaccine clinic but is not 12 years old.  Patient was inadvertently given a 12+ Covid vaccine during the clinic.  No adverse reaction was noted.  Patient stayed almost 25 minutes to be watched for adverse affects.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Anxiety, Cough, Dyspnoea, Electrocardiogram
Clinical narrative: Shortness of breath, anxiety, body aches, cough, lung pain
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Metabolic function test, Pain, Pulmonary pain
Clinical narrative: Shortness of breath, anxiety, body aches, cough, lung pain
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: After Booster, developed Shingles for the first time on lower left back.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes simplex, Oral herpes
Clinical narrative: HSV/Cold sore reactivation post injection day #2
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio decreased, Anion gap decreased, Aspartate aminotransferase normal, Basophil count normal
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood albumin normal, Blood alkaline phosphatase normal, Blood bicarbonate decreased, Blood bilirubin normal, Blood calcium normal
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood chloride increased, Blood creatine phosphokinase increased, Blood creatinine normal, Blood glucose normal, Blood potassium normal
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium normal, Blood urea normal, Brain natriuretic peptide normal, CSF glucose normal, CSF lymphocyte count normal
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: CSF monocyte count, CSF protein increased, CSF red blood cell count positive, CSF test abnormal, CSF white blood cell count increased
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Carbon dioxide decreased, Cervical spinal stenosis, Chest X-ray abnormal, Differential white blood cell count, Eosinophil count decreased
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Facet joint syndrome, Gait disturbance, Globulins increased, Glomerular filtration rate normal, Guillain-Barre syndrome
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Immature granulocyte count, Immunoglobulin therapy, Intervertebral disc degeneration
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Intervertebral disc protrusion, Intervertebral disc space narrowing, Lumbar puncture, Lumbar spinal stenosis, Lymphocyte count decreased
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging neck, Magnetic resonance imaging spinal abnormal, Magnetic resonance imaging thoracic abnormal, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume normal, Monocyte count decreased, Muscle atrophy, Muscular weakness, Neurological examination
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Neutrophil count, Pelvic pain, Platelet count normal, Protein total increased, Red blood cell count decreased
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell nucleated morphology, Red blood cell sedimentation rate normal, Red cell distribution width normal, Scan with contrast abnormal, Spinal retrolisthesis
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Spondylolisthesis, Troponin I normal, Ultrasound Doppler, Ultrasound scan normal, Vertebral foraminal stenosis
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vertebral osteophyte, Walking aid user, White blood cell count, White blood cell count decreased, X-ray
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray of pelvis and hip abnormal
Clinical narrative: Patient received his COVID-19 mRNA vaccine #3 (booster) on 11/16/2021.  The following day (11/17/2021), he noticed weakness of both legs, such that he had difficulty lifting his legs to get into his work truck.   The weakness progressed over the next few days to the point that even walking was difficult, necessitating use of a walking cane.  When standing, he feels a cramping discomfort in the posterior pelvis.  MRI of the entire spine was performed, demonstrating multilevel degenerative disc disease.  There are no imaging findings to account for his presentation.    Cerebrospinal fluid shows albuminocytologic dissociation.  He was seen in consultation by neurology.  He has reflexes on exam, and it is felt that we are seeing him early in the course of Guillain-Barre Syndrome secondary to the COVID-19 mRNA vaccine, with progressive bilateral lower extremity weakness starting 1 day after administration.  He was treated with IVIG.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram cerebral abnormal, Anticoagulant therapy, Cavernous sinus thrombosis, Headache, Laboratory test
Clinical narrative: Patient began to experience headaches on 10/29 about 2 weeks after administration of the second COVID19 vaccine. He was admitted to the hospital. Labs and imaging obtained. Head imaging showed sphenoid sinusitis. MRI/MRA showing suspected left greater than right cavernous sinus thrombosis, likely secondary to sphenoid sinusitis, with associated mild narrowing of the left cavernous internal carotid artery. Patient started on anticoagulation and discharged home on anticoagulation. He also went to the OR on 11/21 for sphenoidotomy and drainage of fluid. Cavernous sinus thrombosis likely secondary to sphenoid sinusitis but because of the timing of second vaccine consulted ID who recommended submitting VAERS form and sending platelet factor 4 antibody- still pending.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head abnormal, Platelet factor 4, Sinusitis, Sphenoid sinus operation
Clinical narrative: Patient began to experience headaches on 10/29 about 2 weeks after administration of the second COVID19 vaccine. He was admitted to the hospital. Labs and imaging obtained. Head imaging showed sphenoid sinusitis. MRI/MRA showing suspected left greater than right cavernous sinus thrombosis, likely secondary to sphenoid sinusitis, with associated mild narrowing of the left cavernous internal carotid artery. Patient started on anticoagulation and discharged home on anticoagulation. He also went to the OR on 11/21 for sphenoidotomy and drainage of fluid. Cavernous sinus thrombosis likely secondary to sphenoid sinusitis but because of the timing of second vaccine consulted ID who recommended submitting VAERS form and sending platelet factor 4 antibody- still pending.
Age: 15.0
Sex: M
Vaccine: FLU4
Symptoms: Asthenia, Pallor
Clinical narrative: Patient received flu vaccine and did not report any history of adverse events. About 5 minutes later patient returned and was pale and felt like they were weak. Patient sat in chair and was monitored. Paramedics arrived about 5 minutes later and monitored patient. Patient was feeling better and able to walk away with parents and parents declined to have patient sent to hospital.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Ear infection, Ear pain, Ear swelling, Lymphadenopathy
Clinical narrative: At 5:30pm day of, I lost my voice and experienced swelling in my lymph nodes on right side of neck.  Upon waking the next morning at 7am, my right ear was swollen, itchy, and uncomfortable, remaining that way and turning more red by bed time. Upon waking today, Friday, at 8, my ear was more swollen, throbbing, and the pain extended into my jaw on the right side, making it impossible to chew food. Pain level 9/10. That entire side sore to touch.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in jaw, Physical examination, Pruritus
Clinical narrative: At 5:30pm day of, I lost my voice and experienced swelling in my lymph nodes on right side of neck.  Upon waking the next morning at 7am, my right ear was swollen, itchy, and uncomfortable, remaining that way and turning more red by bed time. Upon waking today, Friday, at 8, my ear was more swollen, throbbing, and the pain extended into my jaw on the right side, making it impossible to chew food. Pain level 9/10. That entire side sore to touch.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient supposed to receive her first dose of Pediatric Pfizer COVID-19. Instead given Moderna Booster (0.25mL) in error. We informed her mother immediately and explained some signs and symptoms of adverse reactions. I also spoke with her pediatrician and informed them of the discrepancy.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Impaired work ability, Musculoskeletal stiffness
Clinical narrative: Complains of walking more slowly more so 6 weeks after vaccine -Janssen.  He has stiffness in hands.  Has not been able to return to work since 7/16/2021.  He has had history of Gillian Barre in 1999.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was given booster dose as he received Janssen as 1st dose- patient is only 17 years old